XML 29 R11.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting
 12 Months Ended
Jan. 03, 2025
Segment Reporting [Abstract]  
SEGMENT REPORTING SEGMENT REPORTING
We operate in one business segment that focuses on the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Our President and Chief Executive Officer, as the chief operating decision-maker, manages and allocates resources to our operations on a total consolidated basis. Consistent with this decision-making process, our President and Chief Executive Officer uses net income to monitor budget versus actual results for purposes of evaluating performance and to make decisions about the allocation of resources.
Our significant segment expenses are regularly provided to our President and Chief Executive Officer and included in the measure of segment net income of consolidated expenses for our operational departments consisting of drug discovery, development, and selling, general and administrative and other segment items.
Summary of the segment net income, including significant segment expenses were as follows (in thousands):
 Year Ended December 31,
 202420232022
Revenues$2,168,701 $1,830,208 $1,611,062 
Less:
    Cost of goods sold76,216 72,547 57,909 
    Drug discovery94,842 215,085 249,713 
    Development665,847 669,240 521,622 
    Selling, general, and administrative428,962 470,680 397,632 
    Other segment items(1)
298,350 231,678 182,899 
    Interest income(77,156)(86,543)(33,065)
    Provision for income taxes160,373 49,756 52,070 
Segment and consolidated net income$521,267 $207,765 $182,282 
_________________
(1) Other segment items include stock-based compensation expenses, restructuring expenses, impairment of long-lived assets, other research and development expenses including the allocation of general corporate costs to research and development services and development cost reimbursements in connection with certain of our collaboration arrangements, and other income (expenses), net.
All of our long-lived assets are located in the U.S. See “Note 3. Revenues” for enterprise-wide disclosures about product sales, revenues from major customers and revenues by geographic region.